FDA Review Modernization Fully Funded
Generics Modernization Effort At US FDA Receives Full Funding Over Two Years
Executive Summary
After receiving $25.1m in FY 2019, Congress gave another $1.9m in FY 2020, which appropriators said combined reaches the $27m requested for the FY 2020 budget.
You may also be interested in...
Opioid Blister Packs Need Study Before Mandate, Groups Urge
AAM, Upsher-Smith, APhA, and Cigna tell US FDA that packaging requirement will increase manufacturing and drug costs, create reimbursement hurdles and reduce access to medicines. Daiichi-Sankyo supports agency's proposal.
Generic Labeling Problems Targeted In US FDA Budget Request
Agency seeks legislative authority to update outdated generic drug labels when the reference product has been withdrawn.
Opioids, Old Initiatives Dominate FY 2020 US FDA Funding Increase
The agency requested a funding increase in part to implement 2018 legislation intended to combat the opioid crisis, but also to support many initiatives in last year's budget request.